Published in Biol Psychiatry on January 15, 2009
Investigating the Effects of Typhoid Vaccine on Sleep in Healthy Volunteers | NCT02628054
Clinical Trial of the Use of Ketamine in Treatment Resistant Depression | NCT02610712
Preeclampsia Research on Vitamin D, Inflammation, & Depression (PROVIDE) | NCT03018132
Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes | NCT03580967
Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol (2011) 2.87
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry (2013) 2.68
Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry (2010) 2.54
From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull (2014) 2.39
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proc Natl Acad Sci U S A (2011) 2.37
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry (2009) 2.36
Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol (2010) 2.33
Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology (2011) 2.31
Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings. PLoS One (2011) 2.30
Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A (2010) 2.17
The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry (2013) 2.17
Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psychiatry (2010) 2.15
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15
Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther (2011) 2.12
The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J Intern Med (2011) 2.08
Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA methylation in adolescence. Child Dev (2011) 2.07
Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosom Med (2010) 2.06
Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol (2009) 1.96
Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry (2010) 1.95
How might circadian rhythms control mood? Let me count the ways... Biol Psychiatry (2013) 1.95
Sex Differences in the Peripheral Immune System in Patients with Depression. Front Psychiatry (2017) 1.90
Maternal warmth buffers the effects of low early-life socioeconomic status on pro-inflammatory signaling in adulthood. Mol Psychiatry (2010) 1.90
Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci (2012) 1.90
Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. PLoS One (2012) 1.89
Neural sensitivity to social rejection is associated with inflammatory responses to social stress. Proc Natl Acad Sci U S A (2010) 1.87
Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology (2010) 1.87
Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav Immun (2010) 1.85
Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry (2011) 1.81
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med (2013) 1.78
Harsh family climate in early life presages the emergence of a proinflammatory phenotype in adolescence. Psychol Sci (2010) 1.68
Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci (2012) 1.67
Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry (2010) 1.66
Childhood maltreatment and obesity: systematic review and meta-analysis. Mol Psychiatry (2013) 1.64
Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin Neurosci (2011) 1.63
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One (2010) 1.62
Black sheep get the blues: a psychobiological model of social rejection and depression. Neurosci Biobehav Rev (2010) 1.62
Healthy young women with serotonin transporter SS polymorphism show a pro-inflammatory bias under resting and stress conditions. Brain Behav Immun (2009) 1.61
Is depression an inflammatory disorder? Curr Psychiatry Rep (2011) 1.60
Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab (2010) 1.58
Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2014) 1.57
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation (2011) 1.56
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience (2013) 1.55
Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. Biol Psychiatry (2014) 1.54
Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.50
Depression, Asthma, and Bronchodilator Response in a Nationwide Study of US Adults. J Allergy Clin Immunol Pract (2015) 1.49
Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry (2012) 1.48
Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety (2013) 1.48
Immune suppression and immune activation in depression. Brain Behav Immun (2010) 1.48
Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci (2011) 1.48
The role of inflammation in suicidal behaviour. Acta Psychiatr Scand (2015) 1.47
Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord (2012) 1.46
Depression and coronary heart disease. Nat Rev Cardiol (2016) 1.45
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology (2011) 1.44
Biological embedding of stress through inflammation processes in childhood. Mol Psychiatry (2010) 1.42
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry (2012) 1.41
Depression and immunity: a role for T cells? Brain Behav Immun (2009) 1.40
Trajectories of change in obesity and symptoms of depression: the CARDIA study. Am J Public Health (2010) 1.39
Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol (2010) 1.38
Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample. Psychol Med (2010) 1.38
Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry (2010) 1.37
Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol (2012) 1.35
The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J (2013) 1.32
Animal models of depression: molecular perspectives. Curr Top Behav Neurosci (2011) 1.31
Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology (Berl) (2010) 1.31
Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology (2011) 1.31
Anxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis. Front Psychiatry (2014) 1.30
Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry (2014) 1.29
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry (2015) 1.29
Hippocampal gene expression changes underlying stress sensitization and recovery. Mol Psychiatry (2013) 1.28
The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol (2015) 1.28
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med (2016) 1.26
Clustering of depression and inflammation in adolescents previously exposed to childhood adversity. Biol Psychiatry (2012) 1.26
Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumtol (2011) 1.26
Neural acupuncture unit: a new concept for interpreting effects and mechanisms of acupuncture. Evid Based Complement Alternat Med (2012) 1.25
Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology (2010) 1.24
Major depressive disorder is associated with abnormal interoceptive activity and functional connectivity in the insula. Biol Psychiatry (2013) 1.24
Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J Neuroinflammation (2010) 1.24
A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev (2009) 1.24
Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin Neurosci (2009) 1.23
Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci Biobehav Rev (2012) 1.22
Naturalistic observation of health-relevant social processes: the electronically activated recorder methodology in psychosomatics. Psychosom Med (2012) 1.22
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis (2009) 1.22
Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry (2012) 1.22
Inflammatory dietary pattern and risk of depression among women. Brain Behav Immun (2013) 1.22
Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis (2009) 1.21
Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology (2010) 1.21
Meta-analysis of diffusion tensor imaging studies shows altered fractional anisotropy occurring in distinct brain areas in association with depression. Biol Mood Anxiety Disord (2011) 1.19
The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry (2014) 1.19
Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun (2012) 1.18
Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation. Int J Neuropsychopharmacol (2014) 1.18
Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry (2014) 1.18
Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol Psychiatry (2013) 1.18
Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol Psychiatry (2012) 1.17
Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? Neurosci Biobehav Rev (2010) 1.17
Psychiatric disorders: diagnosis to therapy. Cell (2014) 1.16
Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care (2010) 1.15
Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for ω-3 fatty acids. Neuropsychopharmacology (2010) 1.14
Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol Psychiatry (2010) 1.14
Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology (2011) 1.14
Childhood exposure to violence and lifelong health: clinical intervention science and stress-biology research join forces. Dev Psychopathol (2013) 1.14
Mammalian MAP kinase signalling cascades. Nature (2001) 18.89
Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet (2007) 15.96
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Anterior cingulate cortex, error detection, and the online monitoring of performance. Science (1998) 10.91
Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med (2005) 8.65
Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci (2002) 7.57
Multiple dopamine functions at different time courses. Annu Rev Neurosci (2007) 6.18
Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci (2005) 5.97
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab (2001) 5.76
Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev (2006) 5.46
Inflammation and cancer: how hot is the link? Biochem Pharmacol (2006) 5.17
Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry (2001) 4.70
Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci U S A (2007) 4.58
Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med (2001) 4.39
Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab (2000) 4.34
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet (2006) 4.26
Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A (1998) 4.16
CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci (2001) 4.12
Why rejection hurts: a common neural alarm system for physical and social pain. Trends Cogn Sci (2004) 3.95
A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A (2003) 3.82
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry (2001) 3.39
Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry (2006) 3.33
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry (2008) 3.28
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology (2002) 3.24
IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A (2008) 3.19
A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry (2008) 3.08
Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med (2002) 2.96
Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch Gen Psychiatry (2005) 2.94
Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun (2006) 2.89
The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun (2001) 2.89
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry (2007) 2.84
Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev (1996) 2.78
Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun (2006) 2.78
Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun (2007) 2.66
Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation (2008) 2.53
Brain-immune communication pathways. Brain Behav Immun (2007) 2.50
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry (2006) 2.44
Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine (1997) 2.43
Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry (2007) 2.38
Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosom Med (2006) 2.37
Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther (2002) 2.37
Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology (2000) 2.36
The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry (2007) 2.34
Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets (2007) 2.26
Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology (2008) 2.18
The cholinergic anti-inflammatory pathway. Brain Behav Immun (2005) 2.13
The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology (2006) 2.12
Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res (2006) 2.11
Sleep loss activates cellular inflammatory signaling. Biol Psychiatry (2008) 2.11
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer (2005) 2.09
Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology (2005) 2.08
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05
The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem (2008) 2.04
Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry (2008) 1.96
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry (2007) 1.93
Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience (2005) 1.92
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry (2003) 1.90
Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry (2008) 1.85
Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res (2005) 1.84
Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev (2007) 1.82
Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry (2004) 1.82
Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry (2005) 1.80
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry (2008) 1.80
A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology (2007) 1.77
Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry (2008) 1.73
Inflammatory markers and sleep disturbance in major depression. Psychosom Med (2005) 1.72
RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med (2007) 1.71
Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer. Cancer (1998) 1.69
TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry (2006) 1.67
Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol (2002) 1.67
Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry (2003) 1.66
Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience (2003) 1.64
Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci (2003) 1.63
Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology (2007) 1.63
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol (2008) 1.61
Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res (2007) 1.59
Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry (2007) 1.51
Glutamate-mediated glial injury: mechanisms and clinical importance. Glia (2006) 1.51
Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun (2008) 1.42
Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms. J Clin Psychiatry (2005) 1.41
Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry (2008) 1.38
Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology (2003) 1.34
Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr (2008) 1.33
Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J Neurosci (2008) 1.32
Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures. Stem Cells (2008) 1.31
Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry (1993) 1.29
Molecular mechanisms of microglial activation. Adv Neuroimmunol (1996) 1.29
Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. J Neurochem (2006) 1.27
Voltammetric study of the control of striatal dopamine release by glutamate. J Neurochem (2004) 1.27
Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology (2006) 1.25
Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. J Neurosci Res (2004) 1.23
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol (2006) 1.21
Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology (2003) 1.21
Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology (1997) 1.20
Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology (2001) 1.19
Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis. Neuropsychopharmacology (2007) 1.18
Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice. Brain Behav Immun (2006) 1.18
Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res (1991) 1.17
Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology (2011) 2.31
Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology (2008) 2.18
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry (2003) 1.90
Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population. Psychosom Med (2009) 1.69
Major depression drives severity of American Urological Association Symptom Index. Urology (2010) 1.54
IPSS quality of life question: a possible indicator of depression among patients with lower urinary tract symptoms. Can J Urol (2012) 1.54
Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety (2013) 1.48
Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci (Landmark Ed) (2009) 1.38
IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav Immun (2008) 1.30
Effects of mindful-attention and compassion meditation training on amygdala response to emotional stimuli in an ordinary, non-meditative state. Front Hum Neurosci (2012) 1.24
Compassion meditation enhances empathic accuracy and related neural activity. Soc Cogn Affect Neurosci (2012) 1.13
Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations. Brain Behav Immun (2012) 1.11
Promoter polymorphisms of the interferon-alpha receptor gene and development of Interferon-induced depressive symptoms in patients with chronic hepatitis C: preliminary findings. Neuropsychobiology (2005) 1.00
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. Brain Behav Immun (2013) 0.98
The Inventory of Callous and Unemotional Traits: a construct-validational analysis in an at-risk sample. Assessment (2013) 0.98
Innate immune, neuroendocrine and behavioral responses to psychosocial stress do not predict subsequent compassion meditation practice time. Psychoneuroendocrinology (2009) 0.96
Nocturia associated with depressive symptoms. Urology (2011) 0.96
Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue. Brain Behav Immun (2011) 0.92
Painful diabetic neuropathy is more than pain alone: examining the role of anxiety and depression as mediators and complicators. Curr Diab Rep (2011) 0.91
Microbial 'Old Friends', immunoregulation and stress resilience. Evol Med Public Health (2013) 0.88
Integrative physiology of depression and antidepressant drug action: implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depression. Pharmacol Ther (2012) 0.87
Lymphocytes in neuroprotection, cognition and emotion: is intolerance really the answer? Brain Behav Immun (2010) 0.85
Whole-body hyperthermia for the treatment of major depression: associations with thermoregulatory cooling. Am J Psychiatry (2013) 0.84
Do cytokines really sing the blues? Cerebrum (2013) 0.84
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine. Neuropsychopharmacology (2012) 0.84
Can we vaccinate against depression? Drug Discov Today (2012) 0.84
Engagement with Cognitively-Based Compassion Training is associated with reduced salivary C-reactive protein from before to after training in foster care program adolescents. Psychoneuroendocrinology (2012) 0.83
Cytokines, p38 MAP kinase and the pathophysiology of depression. Neuropsychopharmacology (2006) 0.83
Pre-existing brain function predicts subsequent practice of mindfulness and compassion meditation. Neuroimage (2012) 0.83
Childhood microbial experience, immunoregulation, inflammation and adult susceptibility to psychosocial stressors and depression in rich and poor countries. Evol Med Public Health (2012) 0.82
Microbiota, immunoregulatory old friends and psychiatric disorders. Adv Exp Med Biol (2014) 0.80
Ribavirin may be an important factor in IFN-induced neuropsychiatric effects. J Clin Psychiatry (2004) 0.78
Pain and the brain 2: the recognition and management of chronic pain in primary care. J Clin Psychiatry (2009) 0.76
Pathophysiology of pain and depression: the role of dual-acting antidepressants. CNS Spectr (2005) 0.75
Shattered Shangri-la: differences in depressive and anxiety symptoms in students born in Tibet compared to Tibetan students born in exile. Soc Psychiatry Psychiatr Epidemiol (2008) 0.75